Skip to main content

CORRECTION article

Front. Psychiatry, 16 February 2024
Sec. Anxiety and Stress Disorders
Volume 15 - 2024 | https://doi.org/10.3389/fpsyt.2024.1372373

Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

This article is a correction to:

  1. Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

    1. Read original article
Terence H. W. Ching*Terence H. W. Ching1*Lucia AmorosoLucia Amoroso1Calvin BohnerCalvin Bohner1Elizabeth D'AmicoElizabeth D'Amico1Jeffrey EilbottJeffrey Eilbott1Tara EntezarTara Entezar1Madison FitzpatrickMadison Fitzpatrick1Geena FramGeena Fram1Rachael GraziopleneRachael Grazioplene1Jamila HokansonJamila Hokanson1Anastasia JankovskyAnastasia Jankovsky1Stephen A. KichukStephen A. Kichuk1Bradford MartinsBradford Martins1Prerana PatelPrerana Patel1Henry SchaerHenry Schaer1Sarah ShnayderSarah Shnayder1Chelsea WitherowChelsea Witherow1Christopher Pittenger,,,Christopher Pittenger1,2,3,4Benjamin KelmendiBenjamin Kelmendi1
  • 1Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States
  • 2Department of Psychology, Yale University, New Haven, CT, United States
  • 3Center for Brain and Mind Health, Yale University School of Medicine, New Haven, CT, United States
  • 4Child Study Center, Yale University School of Medicine, New Haven, CT, United States

A Corrigendum on
Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

By Ching THW, Amoroso L, Bohner C, D’Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C and Kelmendi B (2024) Front. Psychiatry. 14:1278823. doi: 10.3389/fpsyt.2023.1278823

Error in Author List

In the published article, there was an error in the author list, and Anastasia Jankovsky was erroneously excluded. The corrected author list appears below.

Terence H. W. Ching,1 Lucia Amoroso,1 Calvin Bohner,1 Elizabeth D'Amico,1 Jeffrey Eilbott,1 Tara Entezar,1 Madison Fitzpatrick,1 Geena Fram,1 Rachael Grazioplene,1 Jamila Hokanson,1 Anastasia Jankovsky,1 Stephen A. Kichuk,1 Bradford Martins,1 Prerana Patel,1 Henry Schaer,1 Sarah Shnayder,1 Chelsea Witherow,1 Christopher Pittenger,1-4 Benjamin Kelmendi1

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: obsessive-compulsive disorder, psilocybin, psychedelic, non-directive support, waitlist, treatment, mental health, adult psychiatry

Citation: Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C and Kelmendi B (2024) Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings. Front. Psychiatry 15:1372373. doi: 10.3389/fpsyt.2024.1372373

Received: 17 January 2024; Accepted: 01 February 2024;
Published: 16 February 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Ching, Amoroso, Bohner, D'Amico, Eilbott, Entezar, Fitzpatrick, Fram, Grazioplene, Hokanson, Jankovsky, Kichuk, Martins, Patel, Schaer, Shnayder, Witherow, Pittenger and Kelmendi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Terence H. W. Ching, terence.ching@yale.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.